Stock Movers

Stock Movers

By iHeartPodcastsNewsBusiness News
Download on the App Store
  • Favorites

    30

    Followers

  • Typical duration

    5 min

    per episode

Based on Podcast App listening data

Stock Movers episodes

  • Arm Surges, Driven Brands Rises, Navan Strong Earnings

    Today's biggest winners and losers in the stock market.

    On this episode of Stock Movers:

    - Arm Holdings Plc (ARM) shares rose by the most in almost a year after the company announced plans to sell its own chips for the first time — a move forecast to generate about $15 billion annually within five years. Meta Platforms Inc. will be the first major customer for the company’s chip, called an AGI CPU, Arm said Tuesday at an event in San Francisco. The product will have as many as 136 cores — a measure of processing power — and draw 300 watts of electricity, according to the UK-based company. Taiwan Semiconductor Manufacturing Co. will produce the chips.

    - Driven Brands (DRVN) rose in extended trading after a Wall Street Journal report that activist ADW Capital is encouraging the automotive services firm to explore a sale or breakup.

    - Navan (NAVN) shares are up after the business travel platform reported earnings and revenue for the fourth quarter that beat the average analyst estimate.

    See omnystudio.com/listener for privacy information.

    4 min
  • Closing Bell: Arm Soars, JetBlue Surges, Energy and Chemical Stocks Fall

    Today's biggest winners and losers in the stock market.

    On this episode of Stock Movers:

    - Arm Holdings Plc (ARM) shares rose by the most in almost a year after the company announced plans to sell its own chips for the first time — a move forecast to generate about $15 billion annually within five years. Meta Platforms Inc. will be the first major customer for the company’s chip, called an AGI CPU, Arm said Tuesday at an event in San Francisco. The product will have as many as 136 cores — a measure of processing power — and draw 300 watts of electricity, according to the UK-based company. Taiwan Semiconductor Manufacturing Co. will produce the chips.

    - JetBlue (JBLU) shares surge after reports from Semafor saying the airline is considering the option of selling itself to a competitor. The US airline has hired advisers to explore the viability of a deal, and is considering scenarios of a tie-up with United Airlines Holdings Inc., Alaska Air Group Inc. or Southwest Airlines Co., and how such a combination would sit in the political and regulatory environment, the publication said.

    - Energy and Chemical stocks fell today as investors weighed Iran rejecting a US ceasefire proposal.

    See omnystudio.com/listener for privacy information.

    9 min
  • JetBlue Soars, Meta Gains, Arm Rises

    Today's biggest winners and losers in the stock market.

    On this episode of Stock Movers:

    JetBlue Airways (JBLU) is considering the option of selling itself to a competitor, Semafor reported, citing people familiar with the matter. The US airline has hired advisers to explore the viability of a deal, and is considering scenarios of a tie-up with United Airlines Holdings Inc., Alaska Air Group Inc. or Southwest Airlines Co., and how such a combination would sit in the political and regulatory environment, the publication said.

    Meta Platforms (META) is cutting several hundred jobs as part of a restructuring effort that’s impacting several teams at the company, including sales, recruiting and the Reality Labs hardware division.

    Arm Holdings (ARM) which made its name licensing technology to semiconductor makers, said it will sell its own chips for the first time — a move forecast to generate about $15 billion annually within five years.

    See omnystudio.com/listener for privacy information.

    6 min
  • KB Home Drops, Sarepta Jumps, ARM Gains on Plans to Sell Its Own Chips

    On this episode of Stock Movers:

    - KB Home (KBH) shares fell after the single-family home builder reported forecast deliveries for the second quarter that missed the average analyst estimate.

    - Sarepta Therapeutics (SRPT) shares jump after the biotech released early clinical data from its siRNA pipeline. Oppenheimer (outperform) analyst Kostas Biliouris says “early DM1/FSHD data appear promising, but full dataset & more markers needed for conclusions”

    - ARM (ARM) shares rise after news it will sell its own chips for the first time, with Meta Platforms Inc. as the first major customer, and expects to generate about $15 billion annually within five years. The company's new chip, called an AGI CPU, will have as many as 136 cores and draw 300 watts of electricity, and will be produced by Taiwan Semiconductor Manufacturing Co.

    See omnystudio.com/listener for privacy information.

    3 min
  • ARM Rises, Chewy Gains, Echostar Up on Report SpaceX to File for IPO Soon as This Week

    On this episode of Stock Movers:

    - ARM (ARM) shares rise after news it will sell its own chips for the first time, with Meta Platforms Inc. as the first major customer, and expects to generate about $15 billion annually within five years. The company's new chip, called an AGI CPU, will have as many as 136 cores and draw 300 watts of electricity, and will be produced by Taiwan Semiconductor Manufacturing Co.

    - Chewy (CHWY) shares gain after the online retailer of pet products gave a net sales forecast for the fiscal year 2027 that beat the average analyst estimate. This suggests the online pet retailer expects strong demand to more than make up for headwinds including inflation and tariff uncertainty.

    - Echostar (SATS) shares are up. EchoStar, Rocket Lab and AST SpaceMobile rally on Wednesday as the Information reports that SpaceX aims to file a prospectus for an initial public offering as soon as this week.

    See omnystudio.com/listener for privacy information.

    4 min
  • Merck to Buy Terns; Pentagon Inks Deals to Boost Production; Chewy Shares Gain

    Today's biggest winners and losers in the stock market.

    On this episode of Stock Movers:

    - Merck (MRK) agreed to buy Terns Pharmaceuticals Inc. for $6.7 billion, giving the multinational company access to a promising new leukemia treatment as it faces the patent expiration of its bestselling cancer drug.

    - The Pentagon has agreed with major defense contractors on a series of framework agreements meant to accelerate production of key missile systems that have seen heavy use during the initial phases of the US and Israeli war against Iran. Lockheed Martin and BAE Systems agreed with the Defense Department on plans to “quadruple the production of seekers for the Terminal High Altitude Area Defense (THAAD) interceptor,” according to a Pentagon announcement.

    - Chewy (CHWY) shares rise after the online retailer of pet products gave a net sales forecast for the fiscal year 2027 that beat the average analyst estimate.

    See omnystudio.com/listener for privacy information.

    5 min
  • Merck to Buy Terns Pharmaceuticals; Arm to Sell Its Own Chips; Braze Shares Climb

    Today's biggest winners and losers in the stock market.
    On this episode of Stock Movers:
    - Merck & Co (MRK) to buy Terns Pharmaceuticals (TERN) for $53/share in cash for an approximate equity value of $6.7 billion.
    - Shares of Arm Holdings (ARM), which made its name licensing technology to semiconductor makers, rose in premarket trading after it said it will sell its own chips for the first time, in a move forecast to generate about $15 billion annually within five years.
    - Braze shares rise after the software company forecast revenue for the first quarter that was higher than the average analyst estimate.

    See omnystudio.com/listener for privacy information.

    5 min
  • KB Homes Down, Arm to Sell Its Own Chips, ImmunityBio Plunges

    Today's biggest winners and losers in the stock market.

    On this episode of Stock Movers:

    - KB Home (KBH) shares are down 5% in postmarket trading Tuesday after the single-family home builder reported forecast deliveries for the second quarter that missed the average analyst estimate.

    - Arm Holdings (ARM) which made its name licensing technology to semiconductor makers, will begin selling its own chips for the first time, adding a business that it expects to generate about $15 billion annually within five years. Shares closed down 1.41%.

    - ImmunityBio (IBRX)shares plunged after the biotechnology company and its billionaire executive chairman, Patrick Soon-Shiong, were hit with a Food and Drug Administration warning letter for false and misleading promotion of its bladder cancer drug Anktiva.

    See omnystudio.com/listener for privacy information.

    4 min
  • Closing Bell: Coal Stocks Rise, Circle Internet Falls, Uber Slides

    Today's biggest winners and losers in the stock market.

    On this episode of Stock Movers:

    - US coal stocks climb on Tuesday as the Iran war continues and the tightened supply of liquefied natural gas is expected to increase demand for coal. Among gainers: Peabody Energy +9.3%, Core Natural Resources +7.0%, Hallador Energy +5.0%, Alliance Resource Partners +2.9%, Alpha Metallurgical Resources +8.7%, Warrior Met Coal +9.4%

    -Circle Internet Group (CRCL) the issuer of the USDC stablecoin, fell the most on record on Tuesday, with investors reacting to potential changes to stablecoin regulation that could make the firm’s cryptocurrency less attractive to large holders. Concerns that a competitor is readying a move into the US market also hurt Circle’s share price. The stock declined as much as 22%, its steepest intraday drop ever, and leading losses across crypto-linked equities.

    - Uber (UBER) shares slide 2.1% on Tuesday as the rideshare giant is in talks to acquire German premium chauffeur services provider Blacklane, Manager Magazin reports citing unidentified people familiar.

    See omnystudio.com/listener for privacy information.

    5 min
  • Concentrix Falls, Jefferies Mixed, ImmunityBio Down as FDA Issues Warning Letter on Cancer Claims

    On this episode of Stock Movers:

    -  Concentrix (CNXC) shares fall as the software company’s second-quarter forecast was weaker than expected. Vital Knowledge also notes “a modest shortfall on FQ1 EPS,” given margin compression.

    - Jefferies (JEF) shares are mixed. Hedge fund founder George Weiss has lost his defamation suit accusing Jefferies Financial Group of running a “smear campaign” to pressure him to pay a $100 million debt owed by his firm, Weiss Multi-Strategy Advisers.

    - ImmunityBio (IBRX) shares fell as much as 25%, the most intraday since 2024, after the FDA warned Anktiva ads are false and misleading, citing unapproved claims and regulatory violations. 

    See omnystudio.com/listener for privacy information.

    3 min

About Stock Movers

From the publisher's feed

Listen for Short conversations on today's biggest winners and losers in the stock market. 

Best of Stock Movers

Ranked by our users in the last 21 days

More shows like Stock Movers

Bloomberg Intelligence by Bloomberg

Bloomberg Intelligence

404 Listeners

Bloomberg Surveillance by Bloomberg

Bloomberg Surveillance

1,163 Listeners

Masters in Business by Bloomberg

Masters in Business

2,178 Listeners

Odd Lots by Bloomberg

Odd Lots

1,972 Listeners

Bloomberg Businessweek by Bloomberg

Bloomberg Businessweek

421 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,036 Listeners

Thoughts on the Market by Morgan Stanley

Thoughts on the Market

1,297 Listeners

Here's Why by Bloomberg

Here's Why

61 Listeners

Wall Street Week by Bloomberg

Wall Street Week

61 Listeners

The Big Take by Bloomberg

The Big Take

154 Listeners

Bloomberg Daybreak: US Edition by Bloomberg

Bloomberg Daybreak: US Edition

86 Listeners

The Markets by Goldman Sachs

The Markets

85 Listeners

Bloomberg News Now by Bloomberg

Bloomberg News Now

72 Listeners

Bloomberg Daybreak: Asia Edition by Bloomberg

Bloomberg Daybreak: Asia Edition

8 Listeners

Bloomberg Daybreak: Europe Edition by Bloomberg

Bloomberg Daybreak: Europe Edition

9 Listeners